Why do we need quality-assured diagnostic tests for sexually transmitted infections?
- PMID: 17109030
- DOI: 10.1038/nrmicro1555
Why do we need quality-assured diagnostic tests for sexually transmitted infections?
Abstract
The bacterial sexually transmitted infections (STIs) syphilis, gonorrhoea and chlamydia can all be cured with a single dose of antibiotic. Unfortunately, however, these infections often remain undiagnosed as many infected individuals have few if any symptoms. Diagnostic tests with high sensitivity and specificity are available for all three infections but, owing to their expense and the lack of laboratory capacity, most people in developing countries do not have access to these tests. There is a great need for simple, cheap diagnostic tests for STIs that can be performed at the point of care, enabling treatment to be given immediately. It is hoped that recent advances in our understanding of the pathogenesis of these infections, and the availability of the complete genome sequences for each causative organism, will lead to the development of improved point-of-care tests that will reduce the burden of these diseases in developing countries.
Similar articles
-
Why do we need quality-assured diagnostic tests for sexually transmitted infections?Nat Rev Microbiol. 2006 Dec;4(12 Suppl):S7-19. doi: 10.1038/nrmicro1569. Nat Rev Microbiol. 2006. PMID: 17110922 Review.
-
Sexually transmitted infections, adverse pregnancy outcome and neonatal infection.Semin Neonatol. 2000 Aug;5(3):255-69. doi: 10.1053/siny.2000.0026. Semin Neonatol. 2000. PMID: 10956450 Review.
-
Sexually transmitted infections in pregnancy: prevalence, impact on pregnancy outcomes, and approach to treatment in developing countries.Sex Transm Infect. 2005 Aug;81(4):294-302. doi: 10.1136/sti.2002.004077. Sex Transm Infect. 2005. PMID: 16061534 Free PMC article. Review.
-
Treatment of sexually transmitted infections in pregnancy.Clin Perinatol. 2005 Sep;32(3):629-56. doi: 10.1016/j.clp.2005.04.007. Clin Perinatol. 2005. PMID: 16085024 Review.
-
Point-of-care tests for diagnosing infections in the developing world.Clin Microbiol Infect. 2010 Aug;16(8):1062-9. doi: 10.1111/j.1469-0691.2010.03279.x. Clin Microbiol Infect. 2010. PMID: 20670288 Review.
Cited by
-
Advances in plasmonic technologies for point of care applications.Chem Rev. 2014 Jun 11;114(11):5728-52. doi: 10.1021/cr4000623. Epub 2014 Apr 18. Chem Rev. 2014. PMID: 24745365 Free PMC article. Review. No abstract available.
-
Improving access to new diagnostics through harmonised regulation: priorities for action.Afr J Lab Med. 2014 Apr 4;3(1):123. doi: 10.4102/ajlm.v3i1.123. eCollection 2014. Afr J Lab Med. 2014. PMID: 29043177 Free PMC article.
-
Epidemiology of curable sexually transmitted infections among women at increased risk for HIV in northwestern Tanzania: inadequacy of syndromic management.PLoS One. 2014 Jul 15;9(7):e101221. doi: 10.1371/journal.pone.0101221. eCollection 2014. PLoS One. 2014. PMID: 25025338 Free PMC article.
-
Droplet-Based Measurements of DNA-Templated Nanoclusters-Towards Point-of-Care Applications.Biosensors (Basel). 2025 Jul 1;15(7):417. doi: 10.3390/bios15070417. Biosensors (Basel). 2025. PMID: 40710067 Free PMC article.
-
Characterizing the intracellular distribution of metabolites in intact Chlamydia-infected cells by Raman and two-photon microscopy.Microbes Infect. 2013 Jun;15(6-7):461-9. doi: 10.1016/j.micinf.2013.03.005. Epub 2013 Mar 27. Microbes Infect. 2013. PMID: 23541981 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical